Latest Headlines
-
Labcorp Presents New Research Demonstrating Clinical Impact Of Precision Diagnostics In Guiding Biomarker-Targeted Therapies For Patients With Epithelial Ovarian Cancer
3/16/2024
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today presented the results from two studies at the 2024 SGO Annual Meeting on Women's Cancer.
-
Revvity Introduces New Workflow To Accelerate Newborn Sequencing Research
3/15/2024
Revvity, Inc. today announced the introduction of a flexible end-to-end workflow solution for newborn research, enabling users to utilize different instruments, reagents and databases based on a lab’s needs.
-
Auburn Community Hospital (ACH) Is The First In The U.S. To Implement Abbott's Newest & Most Advanced Laboratory Technology
3/14/2024
Auburn Community Hospital (ACH) is the first institution in the United States to integrate Abbott's Alinity h‐series into the ACH Core Laboratory. This cutting-edge hematology automation system is set to transform the capabilities of the Auburn Laboratory.
-
New Tuberculosis Test Could Improve TB Care Globally By Increasing Access To Testing In Low- And Middle-Income Countries
3/14/2024
A new tuberculosis (TB) test disclosed in the Association for Diagnostics & Laboratory Medicine's (formerly AACC's) Clinical Chemistry journal would allow testing for TB treatment monitoring to occur outside of a biosafety level 3 (BSL-3) laboratory.
-
Fabric Genomics Partners With Intermountain Children’s Health To Enhance Precision Diagnosis Of Infants And Children Using Whole Genome Sequencing From Broad Clinical Labs
3/13/2024
Fabric Genomics, the leader in artificial intelligence (AI)-powered next generation sequencing interpretation, is announcing a new partnership with Intermountain Children’s Health to analyze the whole genomes of children sequenced by the Broad Clinical Labs to help speed diagnosis of kids who may have genetic diseases.
-
Physicians Lab Launches The First-Of-Its-Kind At-Home Lab Test For Myostatin And Follistatin Levels
3/13/2024
Physicians Lab, a provider of at-home lab testing for integrative medicine and wellness, launched a new at-home lab test that measures the analytes myostatin and follistatin.
-
Beckman Coulter And Fujirebio Expand Partnership To Develop Patient-Friendly, Blood-Based Neurodegenerative Disease Diagnostics
3/12/2024
Beckman Coulter Diagnostics, a clinical diagnostics leader, and Fujirebio, a leader in neurological markers and In Vitro Diagnostic (IVD) manufacturing, today announced an expansion of their partnership focused on development, manufacturing and clinical adoption of neurodegenerative disease assays.
-
Optimal’s SciYbotic Range Of Quality Assurance Equipment Represents A Paradigm Shift In Tablet Testing
3/12/2024
Revolutionising the quality control of tablets, the Optimal Group has developed the SciYbotic range of oral solid dose (OSD) Quality Test Machines for high-speed, at-line operations.
-
Capital Digestive Care Launches AI-Driven LGI-Flag Algorithm For Predicting Lower Gastrointestinal Disorders Including Colorectal Cancer In The United States
3/12/2024
Capital Digestive Care, the largest private gastroenterology (GI) practice in the Mid-Atlantic region, today announced that it is launching LGI-Flag in the United States.
-
Roche Showcases New Navify® Digital Solutions That Generate Operational Insights For Faster Decision-Making In Diagnostics At HIMSS1 2024
3/12/2024
Roche (SIX: RO, ROG; OTCQX: RHHBY) introduces navify Analytics, its suite of cloud-based solutions that provide actionable insights to optimise operational and financial outcomes in laboratories and point of care (POC) settings. navify Analytics for POC will make its debut at the HIMSS 2024 Conference in Orlando, USA, from 11-15 March 2024.